A citation-based method for searching scientific literature

Simonetta Bianchi, Vania Vezzosi. Pathol Oncol Res 2008
Times Cited: 52







List of co-cited articles
199 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Re-evaluating the role of sentinel lymph node biopsy in microinvasive breast carcinoma.
Matthew G Hanna, Shabnam Jaffer, Ira J Bleiweiss, Anupma Nayak. Mod Pathol 2014
14
42

Pathological assessment of microinvasive carcinoma of the breast.
Miki Mori, Koichiro Tsugawa, Hideko Yamauchi, Hiroshi Yagata, Koyu Suzuki, Sachiko Ohde, Kumiko Soejima, Seigo Nakamura. Breast Cancer 2013
15
40

DCIS with Microinvasion: Is It In Situ or Invasive Disease?
Cosette D Champion, Yi Ren, Samantha M Thomas, Oluwadamilola M Fayanju, Laura H Rosenberger, Rachel A Greenup, Carolyn S Menendez, E Shelley Hwang, Jennifer K Plichta. Ann Surg Oncol 2019
19
31

Trends in the treatment of ductal carcinoma in situ of the breast.
Nancy N Baxter, Beth A Virnig, Sara B Durham, Todd M Tuttle. J Natl Cancer Inst 2004
255
9

Ductal carcinoma in situ, complexities and challenges.
Gregory D Leonard, Sandra M Swain. J Natl Cancer Inst 2004
275
9

Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease.
M E Schuh, T Nemoto, R B Penetrante, D Rosner, T L Dao. Arch Surg 1986
97
9

Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida.
Ramsey Camp, Robert Feezor, Ali Kasraeian, Juan Cendan, Scott Schell, Edward Wilkinson, Edward Copeland, Scott Lind. Breast J 2005
32
15

Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
T J Meretoja, P S Heikkilä, K Salmenkivi, M H K Leidenius. Ann Surg Oncol 2012
21
23

Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
C E Cox, K Nguyen, R J Gray, C Salud, N N Ku, E Dupont, L Hutson, E Peltz, G Whitehead, D Reintgen,[...]. Am Surg 2001
166
9

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer.
Wei Zhang, Er-li Gao, Yi-li Zhou, Qi Zhai, Zhang-yong Zou, Gui-long Guo, Guo-rong Chen, Hua-min Zheng, Guan-li Huang, Xiao-hua Zhang. World J Surg Oncol 2012
21
23

Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
Rita Sakr, Martine Antoine, Emmanuel Barranger, Gil Dubernard, Christine Salem, Emile Daraï, Serge Uzan. Breast J 2008
22
18

The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
R F D van la Parra, M F Ernst, P C Barneveld, J M Broekman, M J C M Rutten, K Bosscha. Eur J Surg Oncol 2008
34
11

Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Katrina H Moore, Karl J Sweeney, Meaghan E Wilson, Jessica I Goldberg, Claire L Buchanan, Lee K Tan, Laura Liberman, Roderick R Turner, Michael D Lagios, Hiram S Cody Iii,[...]. Ann Surg Oncol 2007
50
8


Detection of stromal invasion in breast cancer: the myoepithelial markers.
H Yaziji, A M Gown, N Sneige. Adv Anat Pathol 2000
81
7



Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Paul L Nguyen, Alphonse G Taghian, Matthew S Katz, Andrzej Niemierko, Rita F Abi Raad, Whitney L Boon, Jennifer R Bellon, Julia S Wong, Barbara L Smith, Jay R Harris. J Clin Oncol 2008
590
7


HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer.
Robert E Roses, E Carter Paulson, Anupama Sharma, Jeanne E Schueller, Harvey Nisenbaum, Susan Weinstein, Kevin R Fox, Paul J Zhang, Brian J Czerniecki. Cancer Epidemiol Biomarkers Prev 2009
93
7

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
398
7


Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Armando E Giuliano, James L Connolly, Stephen B Edge, Elizabeth A Mittendorf, Hope S Rugo, Lawrence J Solin, Donald L Weaver, David J Winchester, Gabriel N Hortobagyi. CA Cancer J Clin 2017
407
7

Clinicopathologic analysis of a large series of microinvasive breast cancers.
Tamera J Lillemoe, Michaela L Tsai, Karen K Swenson, Barbara Susnik, Janet Krueger, Kendra Harris, Natasha Rueth, Erin Grimm, Joseph W Leach. Breast J 2018
11
36

Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion.
Zhi-Bin Wan, Hong-Yi Gao, Lian Wei, An-Qin Zhang, Jiang-Yu Zhang, Yi Wang, Dong-Dong Wang, Yan Zhang. Medicine (Baltimore) 2018
11
36

Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.
F Magnoni, G Massari, G Santomauro, V Bagnardi, E Pagan, G Peruzzotti, V Galimberti, P Veronesi, V S Sacchini. Br J Surg 2019
17
23

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
452
7

Prognostic classification of breast ductal carcinoma-in-situ.
M J Silverstein, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon. Lancet 1995
506
5

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion.
Yasuhiro Okumura, Yutaka Yamamoto, Zhenhuan Zhang, Tatsuya Toyama, Teru Kawasoe, Mutsuko Ibusuki, Yumi Honda, Ken-ichi Iyama, Hiroko Yamashita, Hirotaka Iwase. BMC Cancer 2008
23
13

Her-2/neu gene amplification in ductal carcinoma in situ of the breast.
Ashraful Hoque, Nour Sneige, Aysegul A Sahin, David G Menter, James W Bacus, Gabriel N Hortobagyi, Scott M Lippman. Cancer Epidemiol Biomarkers Prev 2002
53
5

Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.
Ke-Da Yu, Gen-Hong Di, Jiong Wu, Jin-Song Lu, Kun-Wei Shen, Zhen-Zhou Shen, Zhi-Min Shao. Ann Surg Oncol 2007
58
5

Microinvasive carcinoma of the breast: can it be diagnosed reliably and is it clinically significant?
S A Hoda, M L Prasad, A Moore, R S Hoda, D Giri. Histopathology 1999
16
18

A prognostic index for ductal carcinoma in situ of the breast.
M J Silverstein, M D Lagios, P H Craig, J R Waisman, B S Lewinsky, W J Colburn, D N Poller. Cancer 1996
464
5

Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
Armando E Giuliano, Linda McCall, Peter Beitsch, Pat W Whitworth, Peter Blumencranz, A Marilyn Leitch, Sukamal Saha, Kelly K Hunt, Monica Morrow, Karla Ballman. Ann Surg 2010
802
5

Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.
Armando E Giuliano, Debra Hawes, Karla V Ballman, Pat W Whitworth, Peter W Blumencranz, Douglas S Reintgen, Monica Morrow, A Marilyn Leitch, Kelly K Hunt, Linda M McCall,[...]. JAMA 2011
174
5

Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination.
S Koscielny, M Tubiana, M G Lê, A J Valleron, H Mouriesse, G Contesso, D Sarrazin. Br J Cancer 1984
273
5

Ductal carcinoma in situ of the breast.
Harold J Burstein, Kornelia Polyak, Julia S Wong, Susan C Lester, Carolyn M Kaelin. N Engl J Med 2004
389
5

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, Al B Benson, Diane C Bodurka, Harold J Burstein, Alistair J Cochran, Hiram S Cody, Stephen B Edge, Sharon Galper,[...]. J Clin Oncol 2005
5

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Viviana Galimberti, Bernard F Cole, Stefano Zurrida, Giuseppe Viale, Alberto Luini, Paolo Veronesi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Mattia Intra,[...]. Lancet Oncol 2013
718
5

Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.
M Leidenius, K Salmenkivi, K von Smitten, P Heikkilä. J Surg Oncol 2006
31
9

Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Marianne Kyndi, Flemming B Sørensen, Helle Knudsen, Marie Overgaard, Hanne Melgaard Nielsen, Jens Overgaard. J Clin Oncol 2008
403
5


Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less.
Ji Hyun Kwon, Yu Jung Kim, Keun-Wook Lee, Do-Youn Oh, So Yeon Park, Jee Hyun Kim, Eui Kyu Chie, Sung-Won Kim, Seock-Ah Im, In-Ah Kim,[...]. BMC Cancer 2010
43
6

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
340
5

Breast Cancer Version 2.2015.
William J Gradishar, Benjamin O Anderson, Ron Balassanian, Sarah L Blair, Harold J Burstein, Amy Cyr, Anthony D Elias, William B Farrar, Andres Forero, Sharon Hermes Giordano,[...]. J Natl Compr Canc Netw 2015
128
5

The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
Christine Tunon-de-Lara, Marie Pierre Chauvet, Marie Christine Baranzelli, Marc Baron, Jean Piquenot, Guillaume Le-Bouédec, Fréderique Penault-Llorca, Jean-Rémi Garbay, Jérôme Blanchot, Joëlle Mollard,[...]. Ann Surg Oncol 2015
19
15

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
5


Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?
Hai-Fei Niu, Li-Juan Wei, Jin-Pu Yu, Zhen Lian, Jing Zhao, Zi-Zheng Wu, Jun-Tian Liu. Cancer Biol Med 2016
7
42

Long term prognosis of ductal carcinoma in situ with microinvasion: a retrospective cohort study.
Tianjie Pu, Xiaorong Zhong, Ling Deng, Shi Li, Yan Qiu, Yueping Liu, Hong Zheng, Feng Ye, Hong Bu. Int J Clin Exp Pathol 2018
7
42


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.